Last update 01 Nov 2024

α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor

Basic Info

Related Targets
α-synucleinBeta-N-acetylhexosaminidaseM1 receptor

Related

1
Drugs associated with α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor
ASN-51
Target
Beta-N-acetylhexosaminidase x M1 receptor x α-synuclein
Mechanism
Beta-N-acetylhexosaminidase inhibitors [+2]
Active Org.
Asceneuron SAAsceneuron SA
Originator Org.
Asceneuron SAAsceneuron SA
Active Indication
Amyotrophic Lateral Sclerosis [+1]
Inactive Indication
Alzheimer Disease
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
4
Clinical Trials associated with α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor
NCT06232109 / RecruitingPhase 1
Phase 1, Open-Label, Parallel Group Drug-Drug Interaction Study to Assess the Effect of Fluvoxamine (CYP2C19 Inhibitor), Itraconazole (CYP3A4 Inhibitor) and Paroxetine (CYP2D6 Inhibitor) on the Pharmacokinetics of ASN51 in Healthy Subjects
100 Clinical Results associated with α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor
Login to view more data
100 Translational Medicine associated with α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor
Login to view more data
0 Patents (Medical) associated with α-synuclein x Beta-N-acetylhexosaminidase x M1 receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free